{"id":1567,"date":"2023-04-26T10:29:00","date_gmt":"2023-04-26T02:29:00","guid":{"rendered":"https:\/\/vcro.online\/?p=1567"},"modified":"2024-07-12T10:30:09","modified_gmt":"2024-07-12T02:30:09","slug":"congratulations-a-new-nasal-spray-drug-for-asthma-treatment-has-been-approved-by-the-tfda-to-proceed-with-the-iit-phase-ii-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1567","title":{"rendered":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial"},"content":{"rendered":"\n<p>In April 2023, the professional team from VCRO assisted the client in submitting new nasal spray drug for asthma treatment for clinical trials to TFDA. The team successfully obtained TFDA approval to proceed with investigator initiated trial (IIT) Phase II clinical trial, helping the client smoothly transition to the phase II clinical trial.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In April 2023, the professional team from VCRO assisted the client in submitting new nasal spray drug for asthma treatment for clinical trials to TFDA. The team successfully obtained TFDA approval to proceed with investigator initiated trial (IIT) Phase II clinical trial, helping the client smoothly transition to the phase II clinical trial.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1567","post","type-post","status-publish","format-standard","hentry","category-vcro-express"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial - VCRO<\/title>\r\n<meta name=\"description\" content=\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1567\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1567\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2023-04-26T02:29:00+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-12T02:30:09+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\" \/>\r\n\t<meta property=\"og:image:width\" content=\"512\" \/>\r\n\t<meta property=\"og:image:height\" content=\"512\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1567#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1567\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial\",\"datePublished\":\"2023-04-26T02:29:00+00:00\",\"dateModified\":\"2024-07-12T02:30:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1567\"},\"wordCount\":76,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1567\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1567\",\"name\":\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"datePublished\":\"2023-04-26T02:29:00+00:00\",\"dateModified\":\"2024-07-12T02:30:09+00:00\",\"description\":\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1567#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1567\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1567#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial - VCRO","description":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1567","og_locale":"en_US","og_type":"article","og_title":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial - VCRO","og_description":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1567","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2023-04-26T02:29:00+00:00","article_modified_time":"2024-07-12T02:30:09+00:00","og_image":[{"width":512,"height":512,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","type":"image\/png"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1567#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1567"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial","datePublished":"2023-04-26T02:29:00+00:00","dateModified":"2024-07-12T02:30:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1567"},"wordCount":76,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1567","url":"https:\/\/www.vcro.com.tw\/?p=1567","name":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"datePublished":"2023-04-26T02:29:00+00:00","dateModified":"2024-07-12T02:30:09+00:00","description":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1567#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1567"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1567#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1567"}],"version-history":[{"count":1,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1567\/revisions"}],"predecessor-version":[{"id":1568,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1567\/revisions\/1568"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}